European Blood and Marrow Transplantation Textbook for Nurses: a comprehensive, open-access resource

European Blood and Marrow Transplantation Textbook for Nurses: a comprehensive, open-access resource

VJHemOnc

1 year
48 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
An exciting new resource is available for nurses; The European Blood and Marrow Transplantation (EBMT) Textbook for Nurses. In this interview, Michelle Kenyon, Vice Chair of the EBMT Nurses Group, a Clinical Nurse Specialist from King's College Hospital, London, UK, gives us an overview of this resource. Michelle explains how this open-access e-book is the first book specifically written for nurses with an interest in hematopoietic stem cell transplantation, and highlights the comprehensive coverage offered. This is not the end for this project; she also provides an insight into the future plans to update the e-book and expand its reach. The e-book can be accessed here: http://www.springer.com/us/book/9783319500256. This video was recorded at the EBMT 2018 Annual Meeting, held in Lisbon, Portugal.
Up Next Autoplay
Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits
Light-to-Moderate Exercise May Provide Sickle Cell Disease Benefits
Category: News
1 Views
Cancer-News 54 minutes
Renal Case Presentations
Renal Case Presentations
Category: Kidney Cancer
5 Views
kidneycancer 19 hours
Radiation to Prime the Immune System
Radiation to Prime the Immune System
Category: Kidney Cancer
4 Views
kidneycancer 20 hours
ProVent Trial: When Will There Be Results?
ProVent Trial: When Will There Be Results?
Category: Prostate Cancer
3 Views
CURC 22 hours
How is Immunotherapy Used in Prostate Cancer? @UrologyUS
How is Immunotherapy Used in Prostate Cancer? @UrologyUS
Category: Prostate Cancer
3 Views
CURC 22 hours
ProVent Trial Changing AS Landscape @UrologyUS
ProVent Trial Changing AS Landscape @UrologyUS
Category: Prostate Cancer
3 Views
CURC 23 hours
Current Treatment Options in the ProVent Trial
Current Treatment Options in the ProVent Trial
Category: Prostate Cancer
3 Views
CURC 23 hours
Phase 3 ProVent Clinical Trial @UrologyUS
Phase 3 ProVent Clinical Trial @UrologyUS
Category: Prostate Cancer
4 Views
CURC 1 day
Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma
Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma
Category: Kidney Cancer
7 Views
kidneycancer 2 days
Immune Correlates and Prognostic Significance of CD73 Expression in Renal Cell Carcinoma
Immune Correlates and Prognostic Significance of CD73 Expression in Renal Cell Carcinoma
Category: Kidney Cancer
10 Views
kidneycancer 2 days